Mimedx To Host Shareholder Call On January 18, 2018 To Update Progress On Multiple Clinical Studies And Status Of Patent Portfolio

January 12, 2018

Responsive image

MARIETTA, Ga., Jan. 12, 2018 /PRNewswire/ — MiMedx Group, Inc. (NASDAQ: MDXG), the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue allografts with patent-protected processes for multiple sectors of…

Category: Precious Metals